42 research outputs found
Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA
Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA.BackgroundLGE2 is produced by the cyclooxygenase- or free radical-mediated modification of arachidonate and is formed during the oxidation of low density lipoprotein (LDL) with subsequent adduction to lysine residues in apo B. We have developed a sensitive enzyme-linked sandwich immunosorbent assay (ELISA) for detection and measurement of LGE2-protein adducts as an estimate of oxidation of plasma LDL and Lp(a).MethodsThe assay employs rabbit polyclonal antibodies directed against LGE2-protein adducts that form pyrroles, and alkaline phosphatase-conjugated polyclonal antibodies specific for apo B or apo (a). It demonstrates a high degree of specificity, sensitivity and validity.ResultsEpitopes characteristic for LGE2-pyrroles were quantified in patients with end-stage renal disease (ESRD) that had undergone continuous ambulatory peritoneal dialysis (CAPD) and in a gender- and age-matched control population. In addition to finding that both LDL and Lp(a) levels were elevated in CAPD patients, we also found that plasma Lp(a) but not LDL was more oxidized in CAPD patients when compared to corresponding lipoproteins from healthy subjects. Using density gradient ultracentrifugation of plasma samples, we found that modified Lp(a) floats at the same density as total Lp(a).ConclusionsThe results of this study demonstrate that oxidation of plasma Lp(a) is a characteristic of ESRD patients undergoing CAPD. This ELISA may be useful for further investigations on oxidation of lipoproteins in the circulation of specific patient populations
Inhibition of Integrin α\u3csub\u3ed\u3c/sub\u3eβ\u3csub\u3e2\u3c/sub\u3e-Mediated Macrophage Adhesion to End Product of Docosahexaenoic Acid (DHA) Oxidation Prevents Macrophage Accumulation During Inflammation
A critical step in the development of chronic inflammatory diseases is the accumulation of proinflammatory macrophages in the extracellular matrix (ECM) of peripheral tissues. The adhesion receptor integrin αDβ2 promotes the development of atherosclerosis and diabetes by supporting macrophage retention in inflamed tissue. We recently found that the end product of docosahexaenoic acid (DHA) oxidation, 2-(ω-carboxyethyl)- pyrrole (CEP), serves as a ligand forαDβ2.CEPadduct withECM is generated during inflammation-mediated lipid peroxidation. The goal of this project was to identify a specific inhibitor for αDβ2-CEP interaction that can prevent macrophage accumulation. Using a specially designed peptide library, Biacore-detected protein-protein interaction, and adhesion of integrin-transfected HEK 293 cells, we identified a sequence (called P5 peptide) that significantly and specifically inhibited αD-CEP binding. In the model of thioglycollate-induced peritoneal inflammation, the injection of cyclic P5 peptide reduced 3-fold the macrophage accumulation in WT mice but had no effect in αD-deficient mice. The tracking of adoptively transferred, fluorescently labeled WT and αD-/- monocytes in the model of peritoneal inflammation and in vitro two-dimensional and three-dimensional migration assays demonstrated thatP5peptide does not affectmonocytetransendothelial migration or macrophage efflux from the peritoneal cavity but regulates macrophage migration through the ECM. Moreover, the injection ofP5peptide intoWTmiceona high-fat diet prevents macrophage accumulation in adipose tissue in anαDβ2-dependent manner.Takentogether, these resultsdemonstratetheimportance of αDβ2-mediated macrophage adhesion for the accumulation of infiltrating macrophages in the inflamed ECM and propose P5 peptide as a potential inhibitor of atherogenesis and diabetes
Analysis of Covalent Modifications of Proteins by Oxidized Phospholipids Using a Novel Method of Peptide Enrichment
Free
radical-induced oxidation of phospholipids contributes significantly
to pathologies associated with inflammation and oxidative stress.
Detection of covalent interaction between oxidized phospholipids (oxPL)
and proteins by LC-MS/MS could provide valuable information about
the molecular mechanisms of oxPL effects. However, such studies are
very limited because of significant challenges in detection of the
comparatively low levels of oxPL–protein adducts in complex
biological systems. Current approaches have several limitations, most
important of which is the inability to detect protein modifications
by naturally occurring oxPL. We now report, for the first time, an
enrichment method that can be applied to the global analysis of protein
adducts with various naturally occurring oxPL in relevant biological
systems. This method exploits intrinsic properties of peptides modified
by oxPL, allowing highly efficient enrichment of oxPL-modified peptides
from biological samples. Very low levels of oxPL–protein adducts
(<2 ppm) were detected using this enrichment method in combination
with LC-MS/MS. We applied the method to several model systems, including
oxidation of high density lipoprotein (HDL) and interaction of human
platelets with a specific oxPL, and demonstrated its extremely high
efficiency and productivity. We report multiple new modifications
of apolipoproteins in HDL and proteins in human platelets
Recommended from our members
Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin.
Specific oxidized phospholipids (oxPCCD36) promote platelet hyper-reactivity and thrombosis in hyperlipidemia via the scavenger receptor CD36, however the signaling pathway(s) induced in platelets by oxPCCD36 are not well defined. We have employed mass spectrometry-based tyrosine, serine, and threonine phosphoproteomics for the unbiased analysis of platelet signaling pathways induced by oxPCCD36 as well as by the strong physiological agonist thrombin. oxPCCD36 and thrombin induced differential phosphorylation of 115 proteins (162 phosphorylation sites) and 181 proteins (334 phosphorylation sites) respectively. Most of the phosphoproteome changes induced by either agonist have never been reported in platelets; thus they provide candidates in the study of platelet signaling. Bioinformatic analyses of protein phosphorylation dependent responses were used to categorize preferential motifs for (de)phosphorylation, predict pathways and kinase activity, and construct a phosphoproteome network regulating integrin activation. A putative signaling pathway involving Src-family kinases, SYK, and PLCγ2 was identified in platelets activated by oxPCCD36. Subsequent ex vivo studies in human platelets demonstrated that this pathway is downstream of the scavenger receptor CD36 and is critical for platelet activation by oxPCCD36. Our results provide multiple insights into the mechanism of platelet activation and specifically in platelet regulation by oxPCCD36
Contribution of EDRF and EDHF to restoration of endothelial function following dietary restrictions in hypercholesterolemic rats
505-514The mechanisms underlying the impairment of endothelium-mediated vasorelaxation induced by dietary hypercholesterolemia and the mechanisms of restoration of endothelial function following reintroduction of low cholesterol diet were evaluated. Feeding rats with high cholesterol diet induced hypercholesterolemia and high blood pressure. This was associated with reduced vasorelaxation in response to acetylcholine, isoproterenol, and adenosine. At the same time, exaggerated contractile responses to serotonin and phenylephrine were observed. Reintroduction of a normal diet to cholesterol fed rats resulted in significant normalization of blood pressure, serum lipid profile, relaxation and contractile responses. The contributions of endothelial derived relaxing factors (EDRF), endothelial derived contractile factors (EDCFs)/prostanoids, and endothelial derived hyperpoalrising factor (EDHF) to the vasorelaxation in each group of animals were assessed. EDCFs constricting activity was increased in both cholesterol fed groups as compared to the control group. EDRF and EDHF were found to be the primary factors involved in the regulation of endothelium-mediated responsiveness. In control animals, EDRF was responsible for 70-90% of relaxation, depending on the agonist used. In cholesterol fed animals, EDRF was significantly reduced while EDHF was maintained or enhanced showing that EDHF had a significant role in maintaining the endothelial responses. Importantly, the restoration of vasorelaxation following reintroduction of normal diet was mediated not only by improvement of EDRF-dependent relaxation, but also to a significant extent by a further increase in EDHF-mediated relaxation. Taken together, the data showed that EDRF was attenuated during hypercholesterolemia and dietary interventions with low fat content restored these responses. However, EDHF-mediated responses were not reduced by hypercholesterolemia and subsequently improved their function after application of low cholesterol diet. The results implicate EDHF-mediated relaxation is also an important mechanism for restoration of endothelial function upon application of dietary restrictions for reduction of serum cholesterol level
Mapping and Characterization of the Binding Site for Specific Oxidized Phospholipids and Oxidized Low Density Lipoprotein of Scavenger Receptor CD36*
Recent studies have identified a novel family of oxidized
phosphatidylcholines (oxPCCD36) that serve as highly specific
ligands for scavenger receptor CD36. oxPCCD36 accumulate in
vivo and mediate macrophage foam cell formation as well as promote
platelet hyper-reactivity in hyperlipidemia via CD36. The structural basis of
oxPCCD36 binding to CD36 has not been elucidated. We used
liquid-phase binding to glutathione S-transferase fusion proteins
containing various regions of CD36 to initially identify the region spanning
CD36 amino acids 157-171 to contain a major binding site for
oxPCCD36. A bell-shaped pH profile and salt concentration
dependence suggest an electrostatic mechanism of the binding. Two conserved,
positively charged amino acids in the region 157-171 (lysines at positions 164
and 166) were identified as critical for oxPCCD36 and oxidized low
density lipoprotein (oxLDL) binding to CD36. Lysine neutralization with
chemical modifier or site-directed mutagenesis of lysine 164/166 to alanine or
glutamate, but not to arginine, abolished binding. Cells expressing
full-length CD36 with mutated lysines (164 and 166) failed to recognize
oxPCCD36 and oxLDL. Synthetic peptides mimicking the CD36 binding
site, but not mutated or scrambled peptides, effectively prevented: (i) oxLDL
binding to CD36, (ii) macrophage foam cell formation induced by oxLDL, and
(iii) platelet activation by oxPCCD36. These data indicate that
CD36 (160-168) represents the core of the oxPCCD36 binding site
with lysines 164/166 being indispensable for the binding